Ad is loading...
EVAX
Price
$1.44
Change
-$0.24 (-14.29%)
Updated
Nov 15 closing price
SPRB
Price
$0.49
Change
-$0.03 (-5.77%)
Updated
Nov 15 closing price
115 days until earnings call
Ad is loading...

EVAX vs SPRB

Header iconEVAX vs SPRB Comparison
Open Charts EVAX vs SPRBBanner chart's image
Evaxion Biotech A/S American Depositary Share
Price$1.44
Change-$0.24 (-14.29%)
Volume$76.29K
CapitalizationN/A
Spruce Biosciences
Price$0.49
Change-$0.03 (-5.77%)
Volume$312.18K
CapitalizationN/A
EVAX vs SPRB Comparison Chart
Loading...
EVAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SPRB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
EVAX vs. SPRB commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVAX is a Sell and SPRB is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (EVAX: $1.44 vs. SPRB: $0.49)
Brand notoriety: EVAX and SPRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVAX: 131% vs. SPRB: 70%
Market capitalization -- EVAX: $8.03M vs. SPRB: $20.26M
EVAX [@Biotechnology] is valued at $8.03M. SPRB’s [@Biotechnology] market capitalization is $20.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVAX’s FA Score shows that 0 FA rating(s) are green whileSPRB’s FA Score has 1 green FA rating(s).

  • EVAX’s FA Score: 0 green, 5 red.
  • SPRB’s FA Score: 1 green, 4 red.
According to our system of comparison, SPRB is a better buy in the long-term than EVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVAX’s TA Score shows that 4 TA indicator(s) are bullish while SPRB’s TA Score has 5 bullish TA indicator(s).

  • EVAX’s TA Score: 4 bullish, 4 bearish.
  • SPRB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both EVAX and SPRB are a good buy in the short-term.

Price Growth

EVAX (@Biotechnology) experienced а -42.40% price change this week, while SPRB (@Biotechnology) price change was -8.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

EVAX is expected to report earnings on May 09, 2024.

SPRB is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRB($20.3M) has a higher market cap than EVAX($8.03M). EVAX YTD gains are higher at: -79.000 vs. SPRB (-83.256). EVAX has higher annual earnings (EBITDA): -9.38M vs. SPRB (-42.65M). SPRB has more cash in the bank: 69.7M vs. EVAX (4.58M). SPRB has less debt than EVAX: SPRB (3.69M) vs EVAX (10.5M). SPRB has higher revenues than EVAX: SPRB (9.57M) vs EVAX (3.3M).
EVAXSPRBEVAX / SPRB
Capitalization8.03M20.3M40%
EBITDA-9.38M-42.65M22%
Gain YTD-79.000-83.25695%
P/E RatioN/AN/A-
Revenue3.3M9.57M34%
Total Cash4.58M69.7M7%
Total Debt10.5M3.69M284%
TECHNICAL ANALYSIS
Technical Analysis
EVAXSPRB
RSI
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 20 days ago
82%
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
69%
View a ticker or compare two or three
Ad is loading...
EVAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SPRB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDW10.390.14
+1.37%
Redwire Corp
USAC22.85-0.10
-0.44%
USA Compression Partners LP
ADAP0.59N/A
-0.78%
Adaptimmune Therapeutics plc
DLTR64.20-1.47
-2.24%
Dollar Tree
YGMZ1.11-0.07
-5.93%
MingZhu Logistics Holdings Limited

EVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EVAX has been loosely correlated with KURA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if EVAX jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVAX
1D Price
Change %
EVAX100%
-14.29%
KURA - EVAX
40%
Loosely correlated
-3.46%
SPRC - EVAX
37%
Loosely correlated
-1.82%
SPRB - EVAX
27%
Poorly correlated
-5.83%
REPL - EVAX
26%
Poorly correlated
-5.26%
VNDA - EVAX
26%
Poorly correlated
-1.96%
More

SPRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRB has been loosely correlated with MLEC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRB jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRB
1D Price
Change %
SPRB100%
-5.83%
MLEC - SPRB
51%
Loosely correlated
+0.12%
IMRX - SPRB
49%
Loosely correlated
-7.22%
FATE - SPRB
45%
Loosely correlated
-2.88%
SCPX - SPRB
43%
Loosely correlated
-8.61%
GNFT - SPRB
39%
Loosely correlated
-0.77%
More